An in-depth look to JEIL PHARMA HOLDINGS INC. operating, investing, and financing activities

002620 free cash flow for Q3 24 is 252.44 M KRW. For 2023, 002620 free cash flow was -10.64 B KRW and operating cash flow was -4.42 B KRW.